Ultimately, ophthalmology in the elderly is about more than preserving vision. It is about safeguarding independence, detecting systemic disease, and treating patients holistically. The eye does not exist in isolation from the rest of the body, and nowhere is this more evident than in older patients, where a single red, painful eye may tell a far larger story.
Case reports are an important area of clinical research, as they are a mode of communication with the rest of the medical world about how a specific patient and their disease course. They are valuable because they can highlight learning points with respect to uncommon presentation of a condition, modes of investigation, and of course management of the condition. Although they are not at the top of the evidence pyramid, they are certainly worth getting involved in for many reasons, as writing up a case can help you develop as a clinician, and signify interest in the subject matter.
Artificial intelligence (AI) has rapidly progressed from a research concept to a clinically relevant tool, with Ophthalmology emerging as one of the specialties best suited to its adoption. This is largely due to the image-based nature of ophthalmic investigations, the increasing availability of large datasets, and growing service pressures within eye care systems. This article provides a brief overview of current clinical applications of AI in ophthalmology and highlights key trends.
Glucagon-like peptide-1 (GLP-1) receptor agonists, such tirzepatide and semaglutide, have evolved from specialised diabetes treatments to household brands in recent years. The UK's approach to obesity and type 2 diabetes has changed as a result of its powerful effects on appetite suppression, weight loss, and glycaemic management, with prescriptions increasing in both private clinics and NHS services. Although metabolic and cardiovascular benefits have received most of the emphasis in public and professional discourse, another organ system deserves further consideration: the eyes. Understanding GLP-1 receptor agonists' possible ocular effects- both positive and negative - is becoming more crucial as their use rises.
Despite being the most prevalent primary intraocular cancer in people, uveal melanoma is nevertheless uncommon and sometimes overlooked in public health discourse. In the UK, routine eye exams performed in community optometry settings are the main means of detecting uveal melanoma. Although this approach makes it possible to detect illness before symptoms appear, it may also lead to unforeseen disparities. Patients from lower socioeconomic status (SES) groups may encounter obstacles that affect disease outcomes by delaying detection.
Medical students and foundation doctors are concentrating more on portfolio creation as a result of the increased competition for admission to UK ophthalmology programs in recent years. Senior colleagues often urge prospective applicants to get the so-called "low-hanging fruit" - achievable portfolio points that require comparatively little time input. Simulation training is one such possibility under the ST1 evidence framework for ophthalmology. Simulation seems to provide a significant return on investment, awarding one point for every four hours of pertinent activity. Beneath this seeming accessibility, though, comes a more complicated and unfair reality.
In the UK, undergraduate medical education is changing dramatically. Due to long-term NHS planning and labour constraints, medical school admissions have increased gradually in recent years. The goal of this expansion is to prepare the medical workforce for the future, but it has presented new difficulties for curriculum development and delivery. The amount of time allotted to each speciality during clinical training has frequently decreased as student numbers rise. Particularly impacted has been ophthalmology, which has historically been a minor part of the college curriculum. Teachers are now expected to provide efficient, interesting, and assessment-relevant ophthalmology instruction in progressively shorter amounts of time.
Christmas Eye is also known as “Harvester’s keratitis” due to the strong occupational association with summer harvesting activities, and ‘Albury-Wodonga syndrome’ due to the geographical region to which its incidence is limited, from Canberra to the Albury-Wodonga region of north-east Victoria and south-west New South Wales. This combination makes Christmas Eye a festive nightmare for agricultural workers in this region, with pain often impeding the ability to work.
OphthoBook by Dr Timothy Root presents a concise, approachable, and freely accessible introduction to ophthalmology aimed at medical students, junior doctors, and allied health professionals. Rather than attempting to replicate the breadth of traditional ophthalmology textbooks, the book adopts a focused educational philosophy: to distil the specialty into its most clinically relevant components and present them clear and digestible style.
Brittle cornea syndrome (BCS) is a rare autosomal recessive connective tissue disorder. It is characterised by progressive corneal thinning, corneal ectasia, blue sclera, and marked ocular fragility. These features lead to a significantly increased risk of spontaneous or traumatic corneal perforation. The condition was first described by Stein et al. in 1968 during an attempted surgical repair of a corneal perforation. During suturing, the cornea was observed to fragment easily, highlighting its extreme fragility. The syndrome was later further characterised by Ticho et al., who reported the association of brittle cornea with blue sclera and red hair. In contrast to other connective tissue disorders with ocular involvement, BCS primarily affects the cornea rather than the sclera. This distinction is clinically important, as it has implications for diagnosis, management, and prognosis.